Clinical significance of molecular subtypes of gastrointestinal tract adenocarcinoma

doi:10.4251/wjgo.v14.i3.628

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4706)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

283

WORD

136

HTML

2857

Figures (1-1)

239

Tables (1-1)

272

Sum=3787

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

327

Download

592

Sum=919

Mar 15, 2022 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Oncol. Mar 15, 2022; 14(3): 628-645
Published online Mar 15, 2022. doi: 10.4251/wjgo.v14.i3.628

Open in New Tab Full Size Figure Download Figure

Figure 1 Distribution of major molecular subtypes and the most common predictive biomarker across different tumor types of the gastrointestinal tract. amp: Amplification; CIN: Chromosomally instable; EBV: Epstein-Barr virus; Eg: Epigastric; GS: Stable genome; HM-SNV: Hypermutated-single nucleotide variant; MSI: Microsatellite instability; MSS: Microsatellite stability; TMB: Tumor mutation burden; wt: Wild-type.

Citation: Ignatova EO, Kozlov E, Ivanov M, Mileyko V, Menshikova S, Sun H, Fedyanin M, Tryakin A, Stilidi I. Clinical significance of molecular subtypes of gastrointestinal tract adenocarcinoma. World J Gastrointest Oncol 2022; 14(3): 628-645
URL: https://www.wjgnet.com/1948-5204/full/v14/i3/628.htm
DOI: https://dx.doi.org/10.4251/wjgo.v14.i3.628